Venture capital deals of the week

16/12/2017 18:43
  • Biotech: Gilead Sciences (NASDAQ:GILD) was a strategic investor in a $59.6M Series C round in Hookipa Biotech. The clinical stage biotech has a cytomegalovirus vaccine in phase 2 and cancer candidates derived from two arenavirus-based vector platforms. Hookipa has raised $100.2M to date, according to Crunchbase. 
  • More news on: Gilead Sciences, Inc., Takeda Pharmaceutical Co., Ltd., Baidu, Inc., Tech stocks news, Healthcare stocks news,
  • Read more ...

More News

Costco Is Anything But Dead

16/12/2017 17:54

After being left for dead earlier in the year when Amazon ( AMZN ) closed its transaction for ...

Teva - Aggressive Cuts Provide Relief

16/12/2017 18:04

In early October I looked at the prospects for Teva ( TEVA ) in an article titled, ¨C...

National Beverage: Tread Carefully - From Both Sides

16/12/2017 18:18

When it comes to the Q2 report from LaCroix sparkling water manufacturer National Beverage ( F...

Download our official mobile apps today. is an educational platform. We DO NOT deal with securities and receive any financial benefits from Financial Products & Service Providers.
All Rights Reserved © 2016 - 2018